Source: International Congress 2017 – PG3 Bronchiectasis



Rating:

Share or cite this content

Citations should be made in the following way:
Conroy Wong (Auckland, New Zealand). Anti-inflammatory treatment. International Congress 2017 – PG3 Bronchiectasis

Member's Comments

No comment yet.

Related content which might interest you: Anti-inflammatory, antioxidant and immunomodulatory effects of curcumin in sensitized rat Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Anti-inflammatory effects of add-on atorvastatin therapy during the treatment of COPD patients Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012 Novel anti-inflammatory agents Source: Annual Congress 2009 - Emerging trends in the therapy of COPD Year: 2009 Effects of ulinastatin in treatment of invasive candidiasis Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Pharmacological induction of A20: Anti-inflammatory effects in paediatric asthma Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease Year: 2019 Changes in the anti-inflammatory treatment of COPD Source: Annual Congress 2012 - PG9 Progress on the treatment of COPD Year: 2012 A combination of thyme and ivy exerts potent anti-inflammatory and mucus-normalizing activity in vivo and inhibits 5-LO and PDE4 Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Anti-inflammatory therapies in bronchiectasis Source: Eur Respir Mon 2011; 52: 223-238 Year: 2011 LATE-BREAKING ABSTRACT: GW870086: A potent anti-inflammatory glucocorticoid with a novel pharmacological profile Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013 Update on anti-inflammatory therapy in asthma Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease Year: 2012 Mucolytics and anti-inflammatory lung treatments Source: ERS course 2015 Year: 2015 Antioxidant activity of anticholinergic bronchodilatators Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 Decoy chemokine neutraligands with anti-asthmatic activity Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Inhalations of ultra-low doses of alkylating drug for the treatment of steroid-dependant asthma: anti-inflammatory effect of therapy Source: Eur Respir J 2001; 18: Suppl. 33, 266s Year: 2001 Anti-inflammatory therapy for sarcoidosis patients Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Next generation of anti-inflammatory therapy for COPD? Source: Eur Respir J, 50 (4) 1702084; 10.1183/13993003.02084-2017 Year: 2017